Sign inJoin waitlistJoin the waitlist

Rodney Falk

Director of the Cardiac Amyloidosis Program · Brigham and Women’s Hospital

Credentials: · · · · ·

History

Harvard Medical School
Present

Harvard School of Public Health
1978–1980
Kings College Hospital
1977–1978
Brook General Hospital
1976–1977
City Hospital
1975–1976
University of Birmingham Medical School
1974

Research

Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
Circulation · 2016 · 1,659 citations
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and…
Review · American Journal of Hematology · 2005 · 1,170 citations
The systemic amyloidoses
Review · New England Journal of Medicine · 1997 · First of 3 authors · 915 citations

Sharmila Dorbala
60 papers
MS
Martha Skinner
41 papers
SC
Sarah Cuddy
39 papers · 8 as a fellow
MC
Marcelo Di Carli
27 papers
Frederick Ruberg
24 papers
Raymond Kwong
22 papers
Vaishali Sanchorawala
20 papers
Mathew Maurer
16 papers
DS
David Seldin
15 papers
OC
Olivier Clerc
15 papers
Giada Bianchi
14 papers
John Berk
13 papers

Grants

Molecular Imaging of Primary Amyloid Cardiomyopathy
National Heart, Lung, and Blood Institute · R01
PI · $3.3M · Brigham and Women's Hospital
2016–2022
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $101.7K · Boston University Medical Campus
1997–2004

Clinical trials

24 Month Open Label Study of the Tolerability and Efficacy of Inotersen in TTR Amyloid Cardiomyopathy Patients
Principal investigator · Terminated · Phase 2
Brigham and Women's Hospital
2019–2022
Molecular Imaging of Primary Amyloid Cardiomyopathy
Principal investigator · Recruiting
Brigham and Women's Hospital
2016–2028
The Effect of an Antisense Oligonucleotide to Lower Transthyretin (TTR) Levels on the Progression of -Wild-type TTR Involving the Heart
Principal investigator · Withdrawn · Phase 2
Brigham and Women's Hospital
2016–2018
Doxycycline and TUDCA in Patients With Transthyretin Amyloid Cardiomyopathy
Principal investigator · Completed · Phase 1, Phase 2
Brigham and Women's Hospital
2013–2015